Analysis of the factors influencing the status of coexistence with cancer in young and middle-aged HCC patients after receiving interventional therapy
10.3969/j.issn.1008-794X.2025.07.016
- VernacularTitle:中青年肝癌介入治疗患者与癌症共存状态的影响因素分析
- Author:
Danni LI
1
;
Li YANG
;
Liyan QIU
;
Zhengkeke TAN
;
Longyan WU
;
Xin CHEN
Author Information
1. 530021 广西南宁 广西医科大学第一附属医院护理部
- Keywords:
transcatheter arterial chemoembolization;
long-term condition;
coexistence with disease;
stress adaptation;
perceived social support;
influencing factor
- From:
Journal of Interventional Radiology
2025;34(7):772-776
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the status of coexistence with cancer in young and middle-aged patients with hepatocellular carcinoma(HCC)after receiving interventional therapy,and to analyze the factors influencing the status of coexistence with cancer.Methods Using convenience sampling method,a total of 189 young and middle-aged patients with HCC,who were admitted to a certain grade Ⅲ-A hospital in the Guangxi Zhuang Autonomous Region of China from October 2023 to January 2024,were selected and used as the subjects of research.The general information questionnaire,long-term conditions questionnaire(LTCQ),stress adaptation scale(SAS),and perceived social support scale(PSSS)were used to make the relevant analysis.Results The results of LTCQ analysis showed that in the young and middle-aged HCC patients the mean LTCQ score was(66.28±5.37)points.The multivariate linear regression analysis indicated that age,per capita monthly income of family members,marital status,main caregiver,hepatitis B history,stress adaptability and perceived social support level were the main factors influencing the status of coexistence with cancer(all P＜0.05),explaining 47.0％of the variations.Conclusion The status of coexistence with cancer in young and middle-aged patients with HCC after receiving interventional therapy is at a medium level.Medical workers should implement individualized interventions for patients with different clinical features,so as to improve the quality of life of patients and prevent adverse disease outcomes.
